Lv41
450 积分 2026-06-18 加入
Second-line Treatment Strategy in Unresectable Hepatocellular Carcinoma After First-line Atezolizumab Plus Bevacizumab
3小时前
已完结
Characteristics and outcomes of patients with HCC treated with atezolizumab/bevacizumab, stratified by second line therapy
4小时前
已关闭
Efficacy of Second-line Lenvatinib for Hepatocellular Carcinoma After Early Progression on Atezolizumab–Bevacizumab
4小时前
已完结
Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function
4小时前
已完结
皖公网安备34019202002308
